- Home
- KOD vs PENG Comparison
KOD vs PENG Comparison
Compare KOD & PENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KOD | PENG |
|---|---|---|
| Founded | 2009 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.7B |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | KOD | PENG |
|---|---|---|
| Price | $42.83 | $62.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $35.43 | $27.78 |
| AVG Volume (30 Days) | 506.3K | ★ 2.8M |
| Earning Date | 05-14-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 128.00 |
| EPS | N/A | ★ 1.29 |
| Revenue | N/A | ★ $1,368,794,000.00 |
| Revenue This Year | N/A | $14.55 |
| Revenue Next Year | N/A | $16.14 |
| P/E Ratio | ★ N/A | $46.12 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.29 | $16.04 |
| 52 Week High | $47.84 | $89.86 |
Technical Indicators
Market Signals| Indicator | KOD | PENG |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 54.72 |
| Support Level | $38.72 | $57.62 |
| Resistance Level | $45.23 | $75.32 |
| Average True Range (ATR) | 2.55 | 4.44 |
| MACD | -0.10 | 1.06 |
| Stochastic Oscillator | 52.84 | 96.98 |
Price Performance
Historical ComparisonAbout KOD Kodiak Sciences Inc
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.
About PENG Penguin Solutions Inc. Ordinary Shares
Penguin Solutions Inc is an end-to-end technology company engaged in Intelligent Platform Solutions, Integrated Memory, and Optimized LED business. Its product include Servers, software, OCP HPC & AI system, Racks and Edge. Servers include AMD-based Serves, Intel-based Servers, etc. Software products include Scyld ClusterWare, Scyld Cloud Central, etc. OCP HPC & AI Systems includes OCP Servers & Storage and etc.